Details of the Target
General Information of Target
| Target ID | LDTP04024 | |||||
|---|---|---|---|---|---|---|
| Target Name | Glucagon-like peptide 1 receptor (GLP1R) | |||||
| Gene Name | GLP1R | |||||
| Gene ID | 2740 | |||||
| Synonyms |
Glucagon-like peptide 1 receptor; GLP-1 receptor; GLP-1-R; GLP-1R |
|||||
| 3D Structure | ||||||
| Sequence |
MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDL
FCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPW RDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIH LNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAAN YYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRN SNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLL GTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERW RLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS |
|||||
| Target Type |
Successful
|
|||||
| Target Bioclass |
GPCR
|
|||||
| Family |
G-protein coupled receptor 2 family
|
|||||
| Subcellular location |
Cell membrane
|
|||||
| Function |
G-protein coupled receptor for glucagon-like peptide 1 (GLP-1). Ligand binding triggers activation of a signaling cascade that leads to the activation of adenylyl cyclase and increased intracellular cAMP levels. Plays a role in regulating insulin secretion in response to GLP-1.
|
|||||
| TTD ID | ||||||
| Uniprot ID | ||||||
| DrugMap ID | ||||||
| Ensemble ID | ||||||
| HGNC ID | ||||||
| ChEMBL ID | ||||||
Probe(s) Labeling This Target
ABPP Probe
| Probe name | Structure | Binding Site(Ratio) | Interaction ID | Ref | |
|---|---|---|---|---|---|
|
BTD Probe Info |
![]() |
C341(0.89) | LDD2107 | [1] | |
Competitor(s) Related to This Target
The Interaction Atlas With This Target
The Protein(s) Related To This Target
Other
The Drug(s) Related To This Target
Approved
Phase 3
| Drug Name | Drug Type | External ID | |||
|---|---|---|---|---|---|
| Gma102 | Antibody | DK1MX0 | |||
| Gma105 | Antibody | DO78YZ | |||
| Efpeglenatide | . | D05OZQ | |||
| Glp-1 | . | D08NXW | |||
| Latin T1d | . | D0H1UW | |||
| Taspoglutide | . | D0B1EQ | |||
| Tirzepatide | . | DA69JF | |||
Phase 2
Phase 1
Investigative
Discontinued
| Drug Name | Drug Type | External ID | |||
|---|---|---|---|---|---|
| Cjc-1131 | Small molecular drug | D0L1JE | |||
| Azm-134 | . | D0I0TD | |||
| Cm-glp-1 | . | D00NSM | |||
| Ly-307161 | . | D0Q9HT | |||
| Ly-315902 | . | D0K5HD | |||
| Rg7685 | . | D0M4RX | |||
| Th-0318 | . | D0D2JD | |||

